Alvotech to Present at Upcoming Investor Conferences in November
Key Highlights
- ➤Alvotech management scheduled four investor conference appearances in November
- ➤Events include UBS, Jefferies, DNB Carnegie, and SEB healthcare conferences
- ➤Five Alvotech biosimilars are approved and marketed across multiple global markets
- ➤Pipeline includes nine disclosed biosimilar candidates targeting multiple disease areas
REYKJAVIK, Iceland, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that members of the management team will participate in upcoming investor conferences in November as follows: * UBS Global Biopharma Conference in London– fireside chat Tuesday, November 17 at 14:00 GMT (9:00 am ET). * 2026 Jefferies Global Healthcare Conference in London – presentation on Wednesday, November 18 at 14:30 GMT (9:30 am ET) * DNB Carnegie Healthcare Conference in Oslo – fireside chat on Tuesday, November 24 at 13:20 CET (7:20 am ET). * SEB Healthcare Seminar in Stockholm– fireside chat on Wednesday, November 25 at 10:40 CET (4:40 am ET). Live audio webcasts will be available to investors and the general public on Alvotech’s website on our Events and Presentations page: https://www.alvotech.com/events in the 2026 Q4 section. After the live webcasts, a recording will also be available for up to 90 days.
Get started
Create a free account to read the full story.